Barriers to obesity treatment

European Journal of Internal Medicine

Volumn 19, Issue 3, 2008, Pages 173-180

  Mauro, Marina ^a   Taylor, Valerie ^a   Wharton, Sean ^a   Sharma, Arya M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Barriers; Counseling education; Lifestyle; Medical education; Medication; Obesity therapy; Surgery

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CLOZAPINE; GLUCOCORTICOID; INSULIN; LITHIUM; OLANZAPINE; RISPERIDONE; SULFONYLUREA; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ATTITUDE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC PAIN; COMORBIDITY; ENDOCRINE DISEASE; GASTROINTESTINAL DISEASE; HEALTH PRACTITIONER; HUMAN; MENTAL HEALTH; MUSCULOSKELETAL DISEASE; OBESITY; RECOGNITION; RESPIRATORY TRACT DISEASE; REVIEW; SELF CONCEPT; SIDE EFFECT; SLEEP; SOCIAL STATUS; SUBSTANCE ABUSE; TIME; TRAINING; TREATMENT FAILURE; WEIGHT GAIN; WEIGHT REDUCTION;

ATTITUDE OF HEALTH PERSONNEL; BARIATRICS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIGESTIVE SYSTEM DISEASES; DYSPNEA; ENDOCRINE SYSTEM DISEASES; HEALTH SERVICES ACCESSIBILITY; HUMANS; IATROGENIC DISEASE; MENTAL DISORDERS; OBESITY; PAIN; PHYSICIANS; SLEEP DISORDERS; SOCIAL ENVIRONMENT; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 41349111853     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.09.011     Document Type: Review

References (88)

1. World Health Organization. Obesity: preventing and managing the global epidemic (who technical report series no. 894) (2000), World Health Organization, Geneva
2. Kopelman P.G. Obesity as a medical problem. Nature 404 (2000) 635-643
3. Katzmarzyk P.T., and Janseen I. The economic costs associated with physical inactivity and obesity in Canada: an update. Can J Appl Physiol 29 (2004) 90-115
4. Visscher T.L., Rissanen A., Seidell J.C., Heliövaara M., Knekt P., Reunanen A., et al. Obesity and unhealthy life-years in adult Finns: an empirical approach. Arch Intern Med 164 (2004) 1413-1420
5. Puhl R., and Brownell K.D. Bias, discrimination, and obesity. Obes Res 9 (2001) 788-805
6. Pi-Sunyer F.X. A review of long term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther 18 (1996) 1006-1035
7. Tsai A.G., and Wadden T.A. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med 142 (Jan 4 2005) 56-66
8. Wing R.R., and Phelan S. Long-term weight loss maintenance. Am J Clin Nutr 82 (2005) 222S-225S
9. Lau D.C., Douketis J.D., Morrison K.M., Hramiak I.M., Sharma A.M., Ur E., et al. Canadian clinical practice guidelines on management and prevention of obesity in adults and children. CMAJ 176 (2006) S1-S13
10. Foster G.D., Sarwer D.B., and Wadden T.A. Psychological effects of weight cycling in obese persons: a review and research agenda. Obes Res 5 (1997) 474-488
11. Forman-Hoffman V., Little A., and Wahls T. Barriers to obesity management: a pilot study of primary care clinicians. BMC Fam Pract 7 (Jun 6 2006) 35
12. Merchant A., Yusuf S., and Sharma A.M. A cardiologist's guide to waist management. Heart 92 (2006) 865-866
13. Bray G.A., and Ryan D.H. Drug treatment of the overweight patient. Gastroenterology 132 (2007) 2239-2252
14. Padwal R., Kezouh A., Levine M., and Etminan M. Long-term persistence with orlistat and sibutramine in a population-based cohort. Int J Obes (Lond) (Apr 10 2007) [Electronic publication ahead of print]
15. Kral J.G., and Naslund E. Surgical treatment of obesity. Nat Clin Pract Endocrinol Metab 3 (2007) 574-583
16. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
17. Gastrointestinal surgery for severe obesity. National institutes of health consensus development conference statement. March 1991. Am J Clin Nutr 55 (1992) 615S-619S
18. Sobal J., and Stunkard A.J. Socioeconomic status and obesity: a review of the literature. Psychol Bull 105 (1989) 260-275
19. Block J.P., Scribner R.A., and DeSalvo K.B. Fast food, race/ethnicity, and income: a geographic analysis. Am J Prev Med 27 (2004) 211-217
20. Drewnowski A., and Specter S.E. Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr 79 (2004) 6-16
21. Miles R., and Panton L. The influence of the perceived quality of community environments on low-income women's efforts to walk more. J Commun Health 31 (2006) 379-392
22. Ruelaz A.R., Diefenbach P., Simon B., Lanto A., Arterburn D., and Shekelle P.G. Perceived barriers to weight management in primary care-perspectives of patients and providers. J Gen Intern Med 22 (2007) 518-522
23. Heymsfield S.B., van Mierlo C.A., van der Knaap H.C., Heo M., and Frier H.I. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 27 (2003) 537-549
24. Huerta S., Li Z., Li H.C., Hu M.S., Yu C.A., and Heber D. Feasibility of a partial meal replacement plan for weight loss in low-income patients. Int J Obes Relat Metab Disord 28 (2004) 1575-1579
25. Rollnick S. Behavior change in practice: targeting individuals. Int J Obes Relat Metab Disord 20 (1996) S22-S26
26. Verheijden M.W., Bakx J.C., van Weel C., Koelen M.A., and van Staveren W.A. Role of social support in lifestyle-focused weight management interventions. Eur J Clin Nutr 59 (2005) S179-S186
27. Andrews G. Intimate saboteurs. Obes Surg 7 (1997) 445-448
28. Mustajoki P. Psychosocial factors in obesity. Ann Clin Res 19 (1987) 143-146
29. van Hout G., van Oudheusden I., and van Heck G. Psychological profile of the morbidly obese. Obes Surg 14 (2004) 579-588
30. Spitzer R.L., Yanovski S., Wadden T., Wing R., Marcus M.D., Stunkard A., et al. Binge eating disorder: its further validation in a multisite study. Intl J of Eat Disord 13 (1993) 137-153
31. Wadden T.A., Sarwer D.B., Womble L.G., Foster G.D., McGuckin B.G., and Schimmel A. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 81 (2001) 1001-1024
32. Grilo C.M., White M.A., Masheb R.M., Rothschild B.S., and Burke-Martindale C.H. Relation of childhood sexual abuse and other forms of maltreatment to 12-month postoperative outcomes in extremely obese gastric bypass surgery. Obes Surg 16 (2006) 454-460
33. Janssen I., Craig W.M., Boyce W.F., and Pickett W. Associations between overweight and obesity with bullying behaviors in school-aged children. Pediatrics 113 (2004) 1187-1194
34. Dingemans A.E., Bruna M.J., and Furth E.F. Binge eating disorder: a review. Int J Obes 26 (2002) 299-307
35. McElroy S.L., Hudson J.I., Capece J.A., Beyers K., Fisher A.C., and Rosenthal N.R. Topiramate Binge Eating Disorder Research Group. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 61 (2007) 1039-1048
36. McElroy S.L., Kotwal R., Guerdjikova A.I., Welge J.A., Nelson E.B., Lake K.A., et al. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry 67 (2006) 1897-1906
37. Bocchieri-Ricciardi L.E., Chen E.Y., Munoz D., Fischer S., Dymek-Valentine M., Alverdy J.C., et al. Pre-surgery binge eating status: effect on eating behavior and weight outcome after gastric bypass. Obes Surg 16 (2006) 1198-1204
38. DiMatteo M.R., Lepper H.S., and Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160 (2000) 2101-2107
39. Fava M. Weight gain and antidepressants. J Clin Psychiatry 61 (2000) 37-41
40. Altfas J.R. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry 2 (2002) 9-18
41. Vorona R.D., Winn M.P., Babineau T.W., Eng B.P., Feldman H.R., and Ware J.C. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med. 165 1 (2005 Jan 10) 25-30
42. Copinschi G. Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol 6 6 (2005) 341-347
43. Gami A.S., Caples S.M., and Somers V.K. Obesity and obstructive sleep apnea. Endocrinol Metab Clin N Am 32 (2003) 869-894
44. Resta O., Foschino-Barbaro M.P., Legari G., Talamo S., Bonfitto P., Palumbo A., et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 25 (2001) 669-675
45. Yaggi H.K., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., and Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353 (2005) 2034-2041
46. Wolk R., Kara T., and Somers V.K. Sleep-disordered breathing and cardiovascular disease. Circulation 108 (2003) 9-12
47. Larsson U.E., and Mattsson E. Perceived disability and observed functional limitations in obese women. Int J Obes Relat Metab Disord 25 (2001) 1705-1712
48. Felson D.T., Anderson J.J., Naimark A., Walker A.M., and Meenan R.F. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med 109 (1988) 18-24
49. Flamme C.H. Obesity and low back pain: biology, biomechanics and epidemiology. Orthopade 34 (2005) 652-657
50. Patucchi E., Fatati G., Puxeddu A., and Coaccioli S. Prevalence of fibromyalgia in diabetes mellitus and obesity. Recenti Prog Med 94 (2003) 163-165
51. Sowers J.R. Obesity as a cardiovascular risk factor. Am J Med 115 S8 (2003) 37S-41S
52. Pischon T., and Sharma A.M. Use of beta-blockers in obesity hypertension: potential role of weight gain. Obes Rev 2 (2001) 275-280
53. Scholze J., Grimm E., Herrmann D., Unger T., and Kintscher U. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. Circulation 115 (2007) 1991-1998
54. Sin D.D., Jones R.L., and Man S.F. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Inter Med 162 (2002) 1477-1481
55. Poulain M., Doucet M., Major G.C., Drapeau V., Sériès F., Boulet L.P., et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ 174 (2006) 1297-1299
56. Hedberg A., and Rossner S. Body weight characteristics of subjects on asthma medication. Int J Obes Relat Metab Disord 24 (2000) 1217-1225
57. Forslund H.B., Lindroos A.K., Blomkvist K., Hakeberg M., Berggren U., Jontell M., et al. Number of teeth, body mass index, and dental anxiety in middle-aged Swedish women. Acta Odontol Scand 60 (2002) 346-352
58. Hampel H. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143 (2005) 199-211
59. Nishizawa T., Suzuki H., Nomoto Y., Masaoka T., Hosoda H., Mori M., et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther 24 Suppl 4 (2006) 104-110
60. Stoa-Birketvedt G., Paus P.N., Ganss R., Ingebretsen O.C., and Florholmen J. Cimetidine reduces weight and improves metabolic control in overweight patients with type 2 diabetes. Int J Obes Relat Metab Disord 22 (1998) 1041-1045
61. Norris S.L., Zhang X., Avenell A., Gregg E., Schmid C.H., and Lau J. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 1 (2005) CD004096
62. Thamer C., Machann J., Stefan N., Haap M., Schafer S., Brenner S., et al. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity 15 (2007) 531-538
63. Pittas A.G., and Roberts S.B. Dietary composition and weight loss: can we individualize dietary prescriptions according to insulin sensitivity or secretion status?. Nutr Rev 64 (2006) 435-448
64. Kokkoris P., and Pi-Sunyer F.X. Obesity and endocrine disease. Endocrinol Metab Clin North Am 32 (2003) 895-914
65. Plotz C.M., Knowlton A.I., and Ragan C. The natural history of Cushing syndrome. Am J Med 13 (1952) 597-614
66. Orth D.N. Cushing syndrome. N Engl J Med 332 (1995) 791-803
67. Lovejoy J.C., Bray G.A., Greeson C.S., Klemperer M., Morris J., Partington C., et al. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. Int J Obes Relat Metab Disord 19 (1995) 614-624
68. Ness-Abramof R., and Apovian C.M. Drug-induced weight gain. Drugs Today 41 (2005) 547-555
69. United Kingdom Prospective Diabetes Study Group. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 128 (1998) 165-175
70. Fonseca V. Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med 115 (2003) 42S-48S
71. Davidson M.B., and Peters A.L. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med 102 (1997) 99-110
72. Van de Laar F.A., Lucassen P.L., Akkermans R.P., Van de Lisdonk E.H., Rutten G.E., and Van Weel C. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev 2 (2005) CD003639
73. Amori R.E., Lau J., and Pittas A.G. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 298 (2007) 194-206
74. Gough S.C. A review of human and analogue insulin trials. Diabetes Res Clin Pract 77 (2007) 1-15
75. Zimmermann U., Kraus T., Himmerich H., Schuld A., and Pollmächer T. Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. J Psychiatr Res 37 (2003) 193-220
76. Raeder M.B., Bjelland I., Emil Vollset S., and Steen V.M. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study. J Clin Psychiatry 67 (2006) 1974-1982
77. McElroy S.L., Frye M.A., Altshuler L.L., Suppes T., Hellemann G., Black D., et al. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. Bipolar Disord 9 (2007) 426-434
78. Schwartz T.L., Nihalani N., Virk S., Jindal S., and Chilton M. Psychiatric medication-induced obesity: a review. Obes Rev 5 (2004) 115-121
79. Hopkins R.L., and Leinung M.C. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am 34 (2005) 371-384
80. Hirsch M.S., and Klibanski A. What price progress? Pseudo-Cushing's syndrome associated with antiretroviral therapy in patients with human immunodeficiency virus infection. Clin Infect Dis 27 (1998) 73-75
81. Pischon T., and Sharma A.M. Use of beta-blockers in obesity hypertension: potential role of weight gain. Obes Rev 2 (2001) 275-280
82. Prentice A.M. Alcohol and obesity. Int J Obes 19 S5 (1995) S44-S50
83. Yeomans M.R. Effects of alcohol on food and energy intake in human subjects: evidence for passive and active over-consumption of energy. Br J Nutr 92 (2004) S31-S34
84. Suter P.M. Alcohol, lipid metabolism and body weight. Ther Umsch 57 (2000) 205-211
85. Risser J.A., Vash P.D., and Nieto L. Does prior authorization of sibutramine improve medication compliance or weight loss?. Obes Res 13 (2005) 86-92
86. Adams T.D., Gress R.E., Smith S.C., Halverson R.C., Simper S.C., Rosamond W.D., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
87. Sjöström L., Narbro K., Sjöström C.D., Karason K., Larsson B., Wedel H., et al. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
88. Avidor Y., Still C.D., Brunner M., Buchwald J.N., and Buchwald H. Primary care and subspecialty management of morbid obesity: referral patterns for bariatric surgery. Surg Obes Relat Dis 3 (2007) 392-407